These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 26060744)

  • 21. The intangible costs of overweight and obesity in Germany.
    Meng F; Nie P; Sousa-Poza A
    Health Econ Rev; 2023 Feb; 13(1):14. PubMed ID: 36809392
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Survey of economic burden of hepatitis B-related diseases in 12 areas in China].
    Ma QS; Liang S; Xiao HW; Zhang SX; Zhuang GH; Zou YH; Tan HZ; Liu JC; Zhang YH; Xu AQ; Zhang L; Feng XX; Hu DS; Wang FZ; Cui FQ; Liang XF
    Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Jul; 38(7):868-876. PubMed ID: 28738457
    [No Abstract]   [Full Text] [Related]  

  • 23. Economic burden of chronic migraine in OECD countries: a systematic review.
    Eltrafi A; Shrestha S; Ahmed A; Mistry H; Paudyal V; Khanal S
    Health Econ Rev; 2023 Sep; 13(1):43. PubMed ID: 37656228
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Determinants of household direct and indirect costs: an insight for health-seeking behaviour in Burkina Faso.
    Su TT; Flessa S
    Eur J Health Econ; 2013 Feb; 14(1):75-84. PubMed ID: 21953320
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of costs on Kenyan households' demand for medical care: why time and distance matter.
    Kukla M; McKay N; Rheingans R; Harman J; Schumacher J; Kotloff KL; Levine MM; Breiman R; Farag T; Walker D; Nasrin D; Omore R; O'Reilly C; Mintz E
    Health Policy Plan; 2017 Dec; 32(10):1397-1406. PubMed ID: 29036378
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Economic Impact of Smoking and of Reducing Smoking Prevalence: Review of Evidence.
    Ekpu VU; Brown AK
    Tob Use Insights; 2015; 8():1-35. PubMed ID: 26242225
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cost-of-illness analysis of type 2 diabetes mellitus in Iran.
    Javanbakht M; Baradaran HR; Mashayekhi A; Haghdoost AA; Khamseh ME; Kharazmi E; Sadeghi A
    PLoS One; 2011; 6(10):e26864. PubMed ID: 22066013
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cost analysis of leuprorelin acetate in Japanese pre-menopausal breast-cancer patients: comparison between 6-month and 3-month depot formulations.
    Goto R; Uda A; Hiroi S; Iwasaki K; Takashima K; Kurebayashi J
    J Med Econ; 2017 Nov; 20(11):1163-1169. PubMed ID: 28782387
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Household Health Spending and Impoverishment: Findings from the Households Survey in Shiraz, Iran.
    Khammarnia M; Keshtkaran A; Kavosi Z; Hayati R
    Bangladesh Med Res Counc Bull; 2014 Aug; 40(2):58-62. PubMed ID: 26415341
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Economic cost analysis of malaria case management at the household level during the malaria elimination phase in The People's Republic of China.
    Xia S; Ma JX; Wang DQ; Li SZ; Rollinson D; Zhou SS; Zhou XN
    Infect Dis Poverty; 2016 Jun; 5(1):50. PubMed ID: 27255648
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cost analysis of leuprorelin acetate in Japanese prostate cancer patients: comparison between 6-month and 3-month depot formulations.
    Goto R; Uda A; Hiroi S; Iwasaki K; Takashima K; Oya M
    J Med Econ; 2017 Nov; 20(11):1155-1162. PubMed ID: 28758810
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The social cost of chronic bronchitis in Mexico City: a pilot study].
    Avila-Burgos L; Gutiérrez-Zúñiga C; Hernández-Peña P; OFFtos-Burgoa C; Silva-Aycaguer L
    Salud Publica Mex; 1996; 38(2):128-38. PubMed ID: 8693351
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Burden of epilepsy: a prevalence-based cost of illness study of direct, indirect and intangible costs for epilepsy.
    Gao L; Xia L; Pan SQ; Xiong T; Li SC
    Epilepsy Res; 2015 Feb; 110():146-56. PubMed ID: 25616467
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Catastrophic Costs among Tuberculosis-Affected Households in Egypt: Magnitude, Cost Drivers, and Coping Strategies.
    Ghazy RM; Sallam M; Ashmawy R; Elzorkany AM; Reyad OA; Hamdy NA; Khedr H; Mosallam RA
    Int J Environ Res Public Health; 2023 Feb; 20(3):. PubMed ID: 36768005
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Cost-of-illness in systemic sclerosis: a retrospective study of an Italian cohort of 106 patients].
    Belotti Masserini A; Zeni S; Cossutta R; Soldi A; Fantini F
    Reumatismo; 2003; 55(4):245-55. PubMed ID: 14872224
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The economic burden of chronic non-communicable diseases in rural Malawi: an observational study.
    Wang Q; Brenner S; Kalmus O; Banda HT; De Allegri M
    BMC Health Serv Res; 2016 Sep; 16(1):457. PubMed ID: 27582052
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Household strategies to cope with the economic costs of illness.
    Sauerborn R; Adams A; Hien M
    Soc Sci Med; 1996 Aug; 43(3):291-301. PubMed ID: 8844932
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of direct, indirect, and intangible costs of epilepsy.
    Pato Pato A; Cebrián Pérez E; Cimas Hernando I; Lorenzo González JR; Rodríguez Constenla I; Gude Sampedro F
    Neurologia; 2011; 26(1):32-8. PubMed ID: 21163205
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cost of illness of tuberculosis in tehran in the year 2011.
    Hasoumi M; Nasehi M; Khakian M; Mohseni M; Ziaiifar H; Keykale MS
    Mater Sociomed; 2014 Oct; 26(5):339-42. PubMed ID: 25568635
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
    Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
    Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.